“demyelinating diseases” inherited white matter congenital ... matter diseases.pdfinherited...

10
25/06/2015 1 ANDREA ROSSI, MD Head, Department of Pediatric Neuroradiology G. Gaslini Children’s Research Hospital Genoa Italy [email protected] Inherited white matter diseases Acquired Congenital abnormal formation, destruction, or turnover of myelin destruction of normally formed myelin How should we classify white matter diseases? Ie: MS, ADEM… “demyelinating diseases” How should we differentiate inherited from acquired white matter disorders? Clinical findings motor function impairment, cognitive and behavioral involvement, seizures Neurophysiological studies NCVs, evoked potentials, EEG Laboratory work-up Neuroradiologic studies MRI “pattern recognition” DWI, MRS The concept of symmetry acquired inherited How should we categorize inherited white matter disorders? Mitochondrial disorders Lysosomal disorders Peroxisomal disorders Golgi complex disorders Impractical from a neuroimaging perspective How should we categorize inherited white matter disorders? White matter diseases = Myelinopathies Delayed Arrested Catching up Not catching up Absent Partial Abnormal Demyelination hypomyelination dysmyelination Van der Knaap et al., Radiology 1999 Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach hypomyelination dysmyelination normal hypomyelination dysmyelination

Upload: others

Post on 17-May-2020

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: “demyelinating diseases” Inherited white matter Congenital ... matter diseases.pdfInherited white matter diseases Acquired Congenital abnormal formation, destruction, or turnover

25/06/2015

1

ANDREA ROSSI, MD Head, Department of Pediatric Neuroradiology

G. Gaslini Children’s Research Hospital Genoa – Italy

[email protected]

Inherited white matter diseases

Acquired

Congenital

abnormal formation, destruction, or turnover of myelin

destruction of normally formed myelin

How should we classify white matter diseases?

Ie: MS, ADEM… “demyelinating diseases”

How should we differentiate inherited from acquired white matter disorders?

Clinical findings motor function impairment, cognitive and behavioral involvement, seizures

Neurophysiological studies NCVs, evoked potentials, EEG

Laboratory work-up

Neuroradiologic studies MRI “pattern recognition” DWI, MRS

The concept of symmetry

acquired inherited

How should we categorize inherited white matter disorders?

• Mitochondrial disorders • Lysosomal disorders • Peroxisomal disorders • Golgi complex disorders

Impractical from a neuroimaging perspective

How should we categorize inherited white matter disorders?

White matter diseases = Myelinopathies

Delayed Arrested

Catching up

Not catching up

Absent

Partial

Abnormal

Demyelination

hypomyelination

dysmyelination

Van der Knaap et al., Radiology 1999

Defining and categorizing leukoencephalopathies of unknown origin:

MR imaging approach

hypomyelination

dysmyelination

normal hypomyelination dysmyelination

Page 2: “demyelinating diseases” Inherited white matter Congenital ... matter diseases.pdfInherited white matter diseases Acquired Congenital abnormal formation, destruction, or turnover

25/06/2015

2

How should we study inherited white matter disorders on MRI?

T1 T2 FLAIR T1+c

DWI ADC

How should we study inherited white matter disorders on MRI?

MRS

Inversion Recovery (TI 400 ms) Modulus image

DWI Diffusion-weighted MRI

may enhance the specificity of the MRI work-up

1. Cytotoxic edema Cellular energetic failure

DWI, ADC

2. Vasogenic edema Loss of integrity of BBB

DWI, ADC

3. Intramyelin edema Myelin breakdown

DWI, ADC

DWI: specific patterns

2-week old seizures, stupor,

hypotonia

Restricted diffusion limited to

the myelinated WM at birth

(“myelination map”)

© T

AG

M H

uism

an

DWI

ADC

MSUD maple syrup urine disease

• Deficient activity of branched chain 2-ketoacid decarboxylase

• Accumulation of branched chain amino- and ketoacids in blood and urine

MRS 1H-MR Spectroscopy

N-acetylaspartate (NAA) A marker of viable neurons, reduced with neuron injury, immaturity

Creatine/Phosphocreatine Unknown significance, possibly energy supply

Choline A measure of membrane turnover, increased in infection, inflammation, neoplasm

Lactate Marker of anaerobic metabolism, mitochondrial dysfunction; not normally present

Myo-Inositol (short TE) possibly a marker of glia

Glx (short TE): glutamate release (injury)

Short TE (18-32 ms)

Intermediate TE (144 ms)

Multivoxel CSI

MRS: specific patterns NAA

Cr

Cho

© C

Hof

fman

n

Canavan disease Deficit of

aspartoacyclase enzyme, resulting in NAA accumulation

Creatine deficiency Deficit of creatine

synthesis or transporter,

resulting in Cr decrease

Page 3: “demyelinating diseases” Inherited white matter Congenital ... matter diseases.pdfInherited white matter diseases Acquired Congenital abnormal formation, destruction, or turnover

25/06/2015

3

Lactate

Marker of anaerobic metabolism Not specific of mitochondrial diseases!

F 10 y, unclassified peroxisomal disorder

Rough estimate of presence of CSF lactate

From selective vulnerability…

… to pattern recognition

Alexander D.

X-ALD

L2-HO glutaric a.

MLD

Krabbe d.

12 m

18 m

Disease stages

Metabolic crises

Propionic acidemia

Know your clinical context!

Merosin deficient CMD [MDC1A] LAMA2 6q22-q23

CK

Page 4: “demyelinating diseases” Inherited white matter Congenital ... matter diseases.pdfInherited white matter diseases Acquired Congenital abnormal formation, destruction, or turnover

25/06/2015

4

1. Classified leukoencephalopathies A. Leukoencephalopathies with known biochemical and/or

molecular defect i. Hypomyelinating diseases ii. Dysmyelinating diseases

B. Leukoencephalopathies defined on the basis of clinical and neuroradiological criteria, but still without known defect

2. Unclassified leukoencephalopathies Cases without a specific diagnosis despite extensive

investigations

Classification of inherited white matter diseases

1. Classified leukoencephalopathies A. Leukoencephalopathies with known biochemical and/or

molecular defect i. Hypomyelinating diseases ii. Dysmyelinating diseases

B. Leukoencephalopathies defined on the basis of clinical and neuroradiological criteria, but still without known defect

2. Unclassified leukoencephalopathies Cases without a specific diagnosis despite extensive

investigations

Classification of inherited white matter diseases

Hypomyelinating diseases

The paradigm:

Pelizaeus-Merzbacher disease

The MRI pattern: Diffuse hypomyelination with normal white matter volume

M 4y

primary disturbance in the formation of myelin Patients

are males!

Pelizaeus-Merzbacher Disease (PMD)

Mutations ( >>duplication) of the proteolipid protein (PLP) gene PLP1 Xq22

Clinical features: severe failure to thrive with developmental delay

nystagmus, seizures, spasticity

Infantile form more common Death during 2nd or 3rd decade of life

Normal neonate

primary disturbance in the formation

of myelin

PLIC

PLP: 50% of all CNS myelin

protein

PMD

classic PMD: mutations in the PLP1 gene (Xq22) different mutations spectrum of phenotypes PLP-related disorders

Connatal PMD

Classic PMD

PLP1 null syndrome

Spastic paraplegia (SPG2)

Clinical severity

Age of onset

neonatal infancy childhood adolescence

Clinical and imaging diagnosis:

PMD

No PLP1 mutation

F 22m

Pelizaeus-Merzbacher-like Disease (PMLD)

GJA12 (connexin 47) 1q41-q42 Higher cognitive and intellectual function and greater levels of motor performance, but earlier onset and more rapid neurologic deterioration than PMD

Page 5: “demyelinating diseases” Inherited white matter Congenital ... matter diseases.pdfInherited white matter diseases Acquired Congenital abnormal formation, destruction, or turnover

25/06/2015

5

• PMD • PMD-like disease • H-ABC • 4H syndrome • HCC • Salla disease • 18q- syndrome • Trichothiodystrophy • …and probably many more

Hypomyelinating diseases H-ABC van der Knaap MS. Et al. AJNR 2002;23:1466-74

Hypomyelination with Atrophy of Basal ganglia and Cerebellum

• Slowly progressive spasticity • Extrapyramidal movement

disorders • Cerebellar ataxia • Moderate to severe cognitive

deficit • Genetic basis unknown

c

th

Hypomyelinating leukodystrophy with (or without) Hypodontia and/or Hypogonadotropic Hypogonadism

(HLD7, 8) [4H Syndrome]

POLR3A 10q22.3 POLR3B 12q23 Saitsu et al,. Am J Hum Genet 2011

Variably combined!

©Timmons et al. Neurology 2013

HCC Zara et al. Nat Genet 2006; 38:1111-1113

Hypomyelination with Congenital Cataract

• Psychomotor delay • Congenital cataract • Peripheral neuropathy

Early (<3 y) Partial U-fiber preservation

Late (> 3 y): Increased WM water content

1. Classified leukoencephalopathies A. Leukoencephalopathies with known biochemical and/or

molecular defect i. Hypomyelinating diseases ii. Dysmyelinating diseases

B. Leukoencephalopathies defined on the basis of clinical and neuroradiological criteria, but still without known defect

2. Unclassified leukoencephalopathies Cases without a specific diagnosis despite extensive

investigations

Classification of inherited white matter diseases

• Abnormal myelin formation • Cystic degeneration of myelin • Myelinopathy due to axonal damage

1 Dysmyelinating diseases:

abnormal myelin formation

The paradigms

Metachromatic leukodystrophy Krabbe disease

X-linked adrenoleukodystrophy

Page 6: “demyelinating diseases” Inherited white matter Congenital ... matter diseases.pdfInherited white matter diseases Acquired Congenital abnormal formation, destruction, or turnover

25/06/2015

6

Dysmyelinating diseases: abnormal myelin formation

Metachromatic leukodystrophy

• Caused by cerebroside sulphatase deficiency (chr. 22)

• Accumulation of sulfatides within oligodendrocyes & Schwann cells

• Late infantile, juvenile, and adult variants

• Diagnosis confirmed on serum, leukocyte, and fibroblast arylsulfatase A activity measurements • Brain MRI: “tigroid” pattern of supratentorial leukoencephalopathy with sparing of U fibers

Best diagnostic clue: “tigroid” or “leopard” pattern of the centrum semiovale

relative sparing of perivascular myelin around transmedullary vessels

Dysmyelinating diseases: abnormal myelin formation

Metachromatic leukodystrophy

Dysmyelinating diseases: abnormal myelin formation

Krabbe disease (globoid cell leukodystrophy)

• Caused by galactocerebroside -galactosidase deficiency (chr. 14)

• Accumulation of psychosine within white matter

• Infantile (< 2y) , juvenile, and adult variants

• Diagnosis confirmed on serum, leukocyte, and fibroblast galactocerebrosidase measurements

• CT: thalamic hyperdensities • MRI: white matter

hyperintensities with early sparing of U fibers (possible tigroid pattern!)

• Diffuse WM involvement • Slight PA gradient • “U” fibers may be involved • May simulate a tigroid pattern • Cerebellar, pyramidal tract,

and spinal cord involvement

Dysmyelinating diseases: abnormal myelin formation

Krabbe disease (globoid cell leukodystrophy)

Dysmyelinating diseases: abnormal myelin formation

Krabbe disease (globoid cell leukodystrophy)

Optic chiasm enlargement

Peripheral nerve enhancement

Also MLD!

Disorder of peroxysomal metabolism due to very-long-chain fatty acid-coenzyme A synthetase deficiency [Xq28]

Childhood cerebral form (CCALD): Males, onset 4-8 years Hyperpigmentation (adrenal insufficiency)

Diagnostic clue: symmetric,

peritrigonal WM abnormality involving the

splenium

Dysmyelinating diseases: abnormal myelin formation

X-linked Adrenoleukodystrophy

Page 7: “demyelinating diseases” Inherited white matter Congenital ... matter diseases.pdfInherited white matter diseases Acquired Congenital abnormal formation, destruction, or turnover

25/06/2015

7

Symmetrical hyperintensity of the peritrigonal WM and splenium centrifugal and postero-anterior gradient

spared “U” fibers peripheral CE

“Schaumberg Zones”

1

2

3

1. fully demyelinated 2. inflammation 3. active demyelination

Dysmyelinating diseases: abnormal myelin formation

X-linked Adrenoleukodystrophy X-ALD: Advanced imaging techniques

1 2

3

1 1 2 2

3 3

Typical involvement of the corticospinal tracts

X-ALD

2 Dysmyelinating diseases:

cystic degeneration of myelin

The paradigms

Alexander disease Canavan disease

van der Knaap disease

Common feature: Macrocrania

Fibrinoid WM degeneration due to Rosenthal fibers accumulation within astrocytes GFAP gene, 17q21

Infantile Form: Macrocrania, seizures, developmental delay, hypotonia and death before age 1 Juvenile & adult forms also exist

Diagnostic clues: macrocrania with symmetrical frontal WM involvement dense periventricular rim at CT centrifugal antero-posterior gradient “U” fibers eventually involved

Dysmyelinating diseases: cystic degeneration of myelin

Alexander disease Dysmyelinating diseases: cystic degeneration of myelin

Alexander disease

Page 8: “demyelinating diseases” Inherited white matter Congenital ... matter diseases.pdfInherited white matter diseases Acquired Congenital abnormal formation, destruction, or turnover

25/06/2015

8

Caused by deficiency of aspartoacyclase enzyme, resulting in NAA accumulation ASPA 17pter-p13

Infantile form (3-6 months): Macrocrania, hypotonia, lethargy, seizures, spasticity, optic atrophy, developmental delay

MRI: Diffuse leukoencephalopathy involving the entire WM with centripetal gradient starting from “U” fibers

Dysmyelinating diseases: cystic degeneration of myelin

Canavan disease

• NAA probably has a role in the molecular efflux water pump system

• Excessive NAA leads to water accumulation in WM with resulting spongy degeneration

norm

Diffusely bright, swollen WM Thalami, brainstem, cerebellum

Restricted diffusion = myelin edema

MRS: NAA

Canavan disease: Advanced imaging techniques

Spongiform leukoencephalopathy with discrepantly mild clinical course

MLC1 22q13.33 (60-70% of cases)

Onset during first year with macrocrania, ataxia, spasticity, gait disturbances, slow mental deterioration, seizures

Diagnostic clue: Diffuse leukoencephalopathy with WM swelling and temporal/frontal cysts

Dysmyelinating diseases: cystic degeneration of myelin

Van der Knaap disease Megalencephalic leukoencephalopathy with subcortical cysts [MLC]

vdK disease [MLC]

MLC: Advanced imaging techniques

Page 9: “demyelinating diseases” Inherited white matter Congenital ... matter diseases.pdfInherited white matter diseases Acquired Congenital abnormal formation, destruction, or turnover

25/06/2015

9

3 Dysmyelinating diseases: cavitating myelinopathy

The paradigm

Vanishing White Matter disease Mitochondrial Leukoencephalopathy

• Late infantile-early childhood onset with ataxia, spasticity, but only mild impaired mental capacities

• Normal initial psychomotor development, first clinical manifestation after minor trauma or infection

• Death in 2-6 years

Diagnostic clues: diffuse central WM cavitation superimposed on hypomyelinating pattern

Dysmyelinating diseases: myelinopathy due to axonal damage

Vanishing White Matter disease Childhood ataxia with central hypomyelination [CACH]

5 genes: 14q24, Chr.12, 1p34.1, 3q27, 2p23.3

eucaryotic initiation factor eIF2B Protection of cells from stress mechanisms

Dysmyelinating diseases: myelinopathy due to axonal damage

Vanishing White Matter disease Childhood ataxia with central hypomyelination [CACH]

T1 T2 FLAIR

WM showing areas of CSF-like signal intensity on T1, PD-, and FLAIR

images

Diffuse WM hyperintensity on T2WI with involvement of the

“U” fibers Early hypomyelinating pattern Clinical findings: persistent ataxia following mild head trauma

2004 2002 1999

© L. Meiners and P. Sjiens, Groningen, the Netherlands

VWMD: Advanced imaging techniques

WM GM

Respiratory chain defects (I,II,IV / combined)

PDH deficiency

• extensive WM involvement (swelling, cystic degeneration)

• common involvement of the corpus callosum

• ± basal ganglia or brainstem involvement

• lactate peak on MRS

Leukoencephalopathy and Mitochondria

Page 10: “demyelinating diseases” Inherited white matter Congenital ... matter diseases.pdfInherited white matter diseases Acquired Congenital abnormal formation, destruction, or turnover

25/06/2015

10

• Evidence of Lac in normal-appearing WM indicates global metabolic impairment

• Strong consideration for a diagnosis of mitochondrial disease

Complex I respiratory chain deficiency

1. Classified leukoencephalopathies A. Leukoencephalopathies with known biochemical and/or

molecular defect i. Hypomyelinating diseases ii. Dysmyelinating diseases

B. Leukoencephalopathies defined on the basis of clinical and neuroradiological criteria, but still without known defect

2. Unclassified leukoencephalopathies Cases without a specific diagnosis despite extensive

investigations

Classification of inherited white matter diseases

1. Classified leukoencephalopathies A. Leukoencephalopathies with known biochemical and/or

molecular defect i. Hypomyelinating diseases ii. Dysmyelinating diseases

B. Leukoencephalopathies defined on the basis of clinical and neuroradiological criteria, but still without known defect

2. Unclassified leukoencephalopathies Cases without a specific diagnosis despite extensive

investigations (about 40-50% of cases)

Classification of inherited white matter diseases

Acknowledgments: R. Biancheri, MD, PhD Z. Patay, MD

Thank you!

[email protected]